There has long been a vague supposition that the European Union (EU) has a transposition problem (Groenleer et al. 2010; Kaeding 2006, 2007a, b, 2008a, b, c, 2012; Kaeding and Versluis 2014; Klika 2015a, 2015b; Mastenbroek and Kaeding 2006, 2007; Schmälter 2017; Steunenberg et al. 2006; Steunenberg and Kaeding 2009). This chapter offers a first assessment of the timeliness of national transposition processes for all EU Member States and their respective national pharmacovigilance systems.
CITATION STYLE
Kaeding, M., Schmälter, J., & Klika, C. (2017). Timely and Correct Transposition of Pharmacovigilance across Member States. In Pharmacovigilance in the European Union (pp. 35–43). Springer Fachmedien Wiesbaden. https://doi.org/10.1007/978-3-658-17276-3_4
Mendeley helps you to discover research relevant for your work.